The efficacy of dydrogesterone and human menopausal gonadotropin protocol for ART - Dydrogesteone new protocol

The subjects were 299 women undergoing COS for IVF/ICSI, between July 2016 and April 2017.No significant difference was found in the number of oocytes retrieved (control group: 10.74vs. study group: 10.87, p=0.5461) or viable embryo rate (control group: 68.1% vs. study group: 65.5%, p=0.2161) between the two groups. In the study group, During the follow-up period of FET, a total of 262 FET cycles were completed. At this time, there were no significant differences in the clinical pregnancy rate (49.3% vs. 57.4%, p=0.1905), implantation rate (45.2% vs. 51.7%, p=0.3977), ongoing pregnancy rate (40.7% vs. 45.2%), and early pregnancy loss rate (17.4% vs. 20.0%, p=0.6933) between the control and study groups.